Prevalence and clinical characteristics of persistent airflow limitation in a cohort of adults with asthma and/or chronic obstructive pulmonary disease
Authors
Maarten van den Berge (ORCID: https://orcid.org/0000-0002-9336-7340)
Ricardo del Olmo (ORCID: https://orcid.org/0000-0002-8375-1939)
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Prevalence and clinical characteristics of persistent airflow limitation in a cohort of adults with asthma and/or chronic obstructive pulmonary disease
Maarten van den Berge, Ricardo del Olmo, Hiroshi Inoue, Helen Kathryn Reddel et al.
Citations
2 citations
Journal
Annals of the American Thoracic Society
Topics
Chronic Obstructive Pulmonary Disease (COPD) Research
Field-Weighted Citation Impact (FWCI)
3.04
article
Prevalence and clinical characteristics of persistent airflow limitation in a cohort of adults with asthma and/or chronic obstructive pulmonary disease
Maarten van den Berge, Ricardo del Olmo, Hiroshi Inoue, Helen Kathryn Reddel, Hana Müllerová, Eleni Rapsomaniki, Peter Calverley, Alberto Papi, Christer Janson, David Price, Alvar G.N. Agustí, Richard Beasley, Anastasios Mangelis, Bradley E. Chipps, Rod Hughes
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Annals of the American Thoracic SocietyVol. 23(2)
Institutions
AstraZeneca (United Kingdom) (GB), Kagoshima University (JP), LifeArc (GB), Uppsala University (SE), University Medical Center Groningen (NL), University of Liverpool (GB), University of Groningen (NL), GlaxoSmithKline (United Kingdom) (GB), University of Aberdeen (GB), University of Ferrara (IT), Police Service of Northern Ireland (GB), Woolcock Institute of Medical Research (AU), Capital Allergy and Respiratory Disease Center (US), AstraZeneca (South Korea) (KR), Hospital Fernández (AR), AstraZeneca (France) (FR), AstraZeneca (Netherlands) (NL), AstraZeneca (Singapore) (SG), Hospital Clínic de Barcelona (ES), Observational & Pragmatic Research Institute (SG), AstraZeneca (Switzerland) (CH), Medical Research Institute of New Zealand (NZ), AstraZeneca (Poland) (PL), AstraZeneca (Italy) (IT), Hospital Maria Pia (PT), Universitat de Barcelona (ES), Macquarie University (AU)
OpenAlex Percentile
Openalex Percentile: Top 8%
Topics
Chronic Obstructive Pulmonary Disease (COPD) Research